News and Comments


  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...


  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...

Recent Postings



Multiple Myeloma Intercept (ICPT) Herceptin Genentech Jazz Pharmaceuticals (JAZZ) Alnylam (ALNY) galapagos (GLPG) INNOVIVA (INVA) SERES THERAPEUTICS (MCRB) Vertex (VRTX) KERYX (KERX) Sanofi-Aventis (SAN) Sanofi (SNY) Anacor (ANAC) ARCA (ABIO) SYNTA (SNTA) Exelixis (EXEL) NEKTAR (NKTR)) Vitae Pharmaceuticals (VTAE) Micromet (MITI) AGOS (ARGS) Roche (RHHBY) Elan (ELN) ADVENTRIX (ANX) Spike Therapeutics (ONCE) Sarepta (SRPT) AstraZeneca (AZN) GlaxoSmithKline (GSK) Theravance (THRX) Galena (GALE) KITE (KITE) Alder Biopharmaceuticals (ALDR) NANTKWEST (NK) Sequenom (SQNM) CRISPR Therapeutics (CRSP) Global Cell Therapeutics (GBT) Abbott Laboratories (ABT) Roche (ROCHE) Dendreon (DNDN) ACADIA (ACAD) Rapamune Ionis (IONS) Biocryst (BCRX) Dynavax (DVAX) Agenus (AGEN) Sanofi (SNA) Revlimid (lenolidamide) Sangamo (SGMO) Ocular Therapeutix (OCUL) Ziofpharm (ZIOP) SUNESIS PHARMACEUTICALS (SNSS) Incyte (INCY) TOKAI (TKAOI) C4 Therapeutics Human Genome Sciences (HGSI) Prosensa (RNA) IDERA (IDRA) Valeant Pharmaceuticals International (VRX) Biogen Idec (BIIB) ISIS (ISIS) Telaprevir NOVOCURE (NVCR) Regeneron (REGN) OSI (OSIP) Intrexon (XON) ABBVIE (ABBV) Cytokinetics (CYTK) CEMPRA (CEMP) Human Longevity (HLI) Ariad (ARIA) Idenix (IDIX) BIOMARIN (BMRN) Advaxis (ADXS) Auspex (ASPX) ImmunoGen (IMGN) Gilead (GILD) ZALTRAP™ Trastuzumab-DM1 CompuGen (CGEN) REGULUS (RGLS) Benlysta (belimumab) Ridaforolimus Illumina (ILMN) Bellicum (BLCM) VANDA (VNDA) MODERNA ARGOS (ARGS) RenenxBio (RGNX) Mirati Therapeutics (MRTX) Theravance Bio Pharma (TBPH) Array Pharmaceuticals (ARRY) Aimmune Therapeutics (AIMT) HALOZYME (HALO) Merck (MRK) Amgen (AMGN) Inovio (INO) Adaptimmune (ADAP) AERIE PHARMACEUTICALS GUARDIAN HEALTH PTC Therapeutics (PTCT) Agenus (AGEN Pluristem (PSTI) Intermune (ITMN) Seattle Genetics (SGEN) Prolor Biotech (PBTH) Bristol-Myers Squibb (BMY) Onyx (ONXX) Anadys (ANDS) Zerenex PORTOLA (PTLA) Endometrial Cancer Xoma (XOMA) Velcade (bortezomib) JUNO (JUNO) Tysabri Editas (EDIT)